Cautionary Note Regarding Forward - Looking Statements This presentation contains forward -looking statements that involve a number of risks and uncertainties. Arm Holdings plc (the " Company" or "Arm") cautions readers that any forward -looking information is not a guarantee of future performance and actual results could differ materially from the information expresse d o r implied by these forward -looking statements. When used in this presentation, words such as "may," "might," "will," "could," "would," ...

Forward-Looking Statements Disclaimer This presentation contains "forward-looking statements" within the meaning of the safe harbor provisions of the U.S. Securities Private Litigation Reform Act of 1995. Forward-looking statements include statements containing words such as "expect," "anticipate," "believe, " "project," "will" and similar expressions intended to identify forward-looking statements. These forward-looking statements are based on Gloo's current expectations. Forward-looking statements are sub ...

Change photo For personal use only Creating Value by Providing a Pathway to Decarbonisation 24 March 2026 NAM Disclaimer For personal use only The material contained in this document is a presentation of information about the Group's activities current at the date of the presentation, 24 March 2026, CT. It is provided in summary form and does not purport to be complete. It should be read in conjunction with the Group's periodic reporting and other announcements lodged with the Australian Securities Exchange ...

March 24, 2026 Smithfield Foods Fourth Quarter Fiscal 2025 Legal Disclaimer Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts contained in this presentation, including statements regarding our strategy, future financial condition, future operations, projected costs, prospects, plans, objectives of management, and expected market growth, are forwa ...

Q1 2026 Investor Summary March 24, 2026 Safe Harbor Statement This presentation includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, but are not limited to, statements regarding the Company's expected future financial condition, growth and profitability, results of operations, including revenue and operating income, cash flows, and effective tax ...

Disclaimer This presentation contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, which reflect the current views of Lument Finance Trust, Inc. (NYSE: LFT) ("LFT," the "Company," "we," "our," or "us") with respect to, among other things, the Company's operations and financial performance. You can identify these forward-looking statements by the use of words such as "outlook," "indi ...

2025 Full Year Earnings Confidential. ©Vertical Aerospace Group Ltd 2026. All rights reserved. Disclaimer The following presentation has been prepared by Vertical Aerospace Ltd. ("Vertical," "Company," "we" or "our"). This presentation may not be reproduced or distributed, in whole or in part. No Representations and Warranties The information contained in this presentation is derived from various internal and external sources, is preliminary in nature and is subject to change, and any such changes may be ma ...

Fiscal 2025 Fourth Quarter and Full-Year Results MARCH 24, 2026 CAUTIONARY STATEMENTS Cautionary Note Regarding Forward-Looking Statements This presentation and accompanying discussion may include "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements include, without limitation, all statements other than statements of historical or current facts contained in this presentation including statements relating to our intentions, belief ...

Investor presentation Annual Report 2025 1 January – 31 December 2025 24th March 2026 Disclaimer This presentation (this "Presentation") has been prepared by Cadeler A/S (the "Company") exclusively for information purposes and may not be reproduced or redistributed, in whole or in part, by any other person. Forward-looking statements This Presentation contains certain forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933 and Section 21E of the U.S. Exchange Act of 1 ...

Brendan Strong, SVP, Investor Relations Opening Remarks Richard Paulson, President and Chief Executive Officer Phase 3 SENTRY Topline Results March 24, 2026 On Today's Call Welcome Phase 3 SENTRY Topline Results Dr. Reshma Rangwala, Chief Medical Officer and Head of Research Myelofibrosis Treatment Landscape Dr. John Mascarenhas, Principal Investigator of Phase 3 SENTRY Trial; Professor of Medicine at the Icahn School of Medicine at Mount Sinai and Director of the Center of Excellence for Blood Cancers and ...